Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-CH1/CL) (BSCC-012)

Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-AR antibody variable domain is fused to CH1 and the other scFv from an anti-DNA antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can enter prostate cancer cells and inhibits androgen receptor function. It is designed for the research of prostate cancer therapy.

Datasheet INQUIRY

Specifications

Targets

AR & DNA

Type

scFv-CH1/CL

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Prostate cancer

Targets

Target 1

Gene ID

367

UniProt ID

P10275

Alternative Names

AR; androgen receptor; KD; AIS; TFM; DHTR; SBMA; HYSP1; NR3C4; SMAX1; HUMARA; dihydrotestosterone receptor; androgen nuclear receptor variant 2; nuclear receptor subfamily 3 group C member 4

Target 2

DNA

Alternative Names

DNA; Deoxyribonucleic acid

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-CH1/CL) (BSCC-012). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-012)

Specifications

Targets

Customer Reviews and Q&As